News

Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless ...
Indian drug companies are increasing their presence in the insulin market. They are competing with multinational corporations ...
Read more about Novo Nordisk's stock moves and today's market action. After years of being known for its insulin and diabetes products, Novo Nordisk produced what some have deemed an ...
Novo Nordisk’s once-weekly Sogroya (somapacitan) has proved to be non-inferior to the once-daily growth hormone Norditropin ...